OCS

What one share of Oculis Holding AG holds

Pharmaceutical Preparations

Switzerland, the U.S. and Iceland. We have substantial expertise in therapeutics for the treatment of neuro-ophthalmic and ophthalmic diseases. We are engaged in developing innovative drug candidates that embrace the potential to address significant unmet medical needs.

Oculis Holding AG’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.

Per-share figures
Profit−$2.29
Capex (buildings and equipment)$0.01
Free cash flow−$1.54
Cash and investments$1.96
Book value$4.73

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2020—−$6.15$0.01−$4.98—−$19.14
2021—−$6.39$0.01−$5.46—−$23.99
2022—−$11.86$0.02−$8.81—−$31.13
2023—−$3.31$0.00−$2.05—$3.73
2024—−$2.41$0.01−$1.38—$2.00
2025—−$2.29$0.01−$1.54—$4.73

Common questions about Oculis Holding AG

How much does one share of Oculis Holding AG earn?

Over its latest fiscal year, Oculis Holding AG lost $2.29 for each share.

Does Oculis Holding AG pay a dividend?

Oculis Holding AG didn’t pay a dividend over its latest fiscal year, according to its SEC filings.

What is Oculis Holding AG’s book value per share?

Oculis Holding AG’s book value is $4.73 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of December 31, 2025.

How much cash and debt does each share of Oculis Holding AG have?

Each share of Oculis Holding AG has $1.96 of cash and investments, as of December 31, 2025.

What is Oculis Holding AG’s free cash flow per share?

−$1.54 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.

Has Oculis Holding AG bought back shares?

Oculis Holding AG’s share count rose about 1925% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.